New painkiller candidate MT-8554 tested in healthy men
NCT ID NCT02536209
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested a single dose of MT-8554, a new drug being developed for pain, in 20 healthy men. Researchers measured how the drug affects the body's response to a cold-induced pain test and checked for safety. The goal was to gather initial data, not to treat any condition.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- MT-8554
- What this could lead to
- If successful, this could point toward a new painkiller that works differently from existing options.
- What could go wrong
- This is a very early Phase 1 trial in just 20 healthy people, so it cannot predict real-world pain relief or safety in patients. The drug may not work or could have side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Investigational center
City Name, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test